Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.
Noah ChisamoreKevork DanayanRoger Nelson RodriguesJoshua D Di VincenzoShakila MeshkatZoe DoyleRodrigo MansurLee PhanFarhan FancyEdmond ChauAniqa TabassumKevin KratiukAnil ArekapudiRoger S McIntyreJoshua Daniel RosenblatPublished in: Journal of psychopharmacology (Oxford, England) (2023)
Ketamine was associated with comparable clinical benefits, safety, and tolerability in a TAY sample as compared to a matched GA TRD sample.